Plaques Are Tombstones, Not Killers

The "Inside-Out" Pathogenesis of Alzheimer’s Disease: A Comprehensive Analysis of the PANTHOS-Mediated Transition from Intraneuronal Pathology to Extracellular Plaque Deposition and Accelerated Neurodegeneration

Benjamin Aaron Gustafsson AdultCognitiveDisease.com

---

1. Introduction: The Paradigm Shift in Alzheimer’s Neuropathology

The pathogenesis of Alzheimer’s disease (AD) has, for decades, been conceptually dominated by the Amyloid Cascade Hypothesis, a framework positing that the gradual extracellular deposition of beta-amyloid (A$\beta$) peptides is the primary initiating event that subsequently triggers neurotoxicity, tau pathology, and cognitive decline. However, a growing body of high-resolution neuropathological evidence, particularly from the Nixon laboratory and corroborated by independent studies, supports an alternative, more mechanistically integrated "Inside-Out" model. This paradigm, visually represented in the time-course diagram of AD progression, centers on the catastrophic failure of the neuronal autophagic-lysosomal system. This failure culminates in the formation of "poisonous flower" (PANTHOS) profiles—neurons engorged with undegraded autophagic vacuoles—which serve as the precursors to senile plaques.¹

The user's query specifically targets the mechanism of progression after this intraneuronal phase. To answer this requires a meticulous deconstruction of the transition from a living, albeit metabolically compromised, neuron to a ruptured cellular "ghost" that constitutes the dense-core amyloid plaque. This report provides an exhaustive analysis of this transition. It details the molecular machinery driving Lysosomal Membrane Permeabilization (LMP), the specific cascades of regulated cell death (such as parthanatos and lysosomal cell death) that ensue, the recruitment of glial cells that act as "excavators" of the cellular debris, and the subsequent propagation of neurofibrillary tau pathology. Furthermore, this analysis integrates the broader implications of this mechanism, including the role of specific genetic risk factors like APOE and TREM2, the impact of vascular and metabolic comorbidities, and the "accelerated neurodegeneration" that characterizes the post-plaque phase of the disease.

1.1 Redefining the "Intraneuronal" Baseline Before elucidating the downstream progression, it is essential to rigorously define the terminal state of the intraneuronal phase. The "Intraneuronal" curve in the diagram represents a period of silent but escalating proteostatic failure. This is not merely the passive accumulation of peptide; it is a dynamic dysfunction of the endosomal-lysosomal network (ELN). The primary driver is the acidification deficit of the lysosome. In AD, particularly in lineages with PSEN1 mutations or APP duplication (as in Down syndrome), the vacuolar ATPase (v-ATPase) proton pump fails to maintain the requisite acidic pH (4.5–5.0).⁴ This alkalization inhibits pH-sensitive proteases, such as cathepsin D and B, rendering them incapable of degrading their substrates.⁶ Consequently, autophagic vacuoles (AVs) containing amyloid precursor protein (APP) C-terminal fragments (β-CTF) and Aβ peptides accumulate. The neuron, sensing a deficit in nutrient recycling, upregulates autophagy, creating a vicious cycle where more substrates are pumped into a system that cannot degrade them.¹ This results in the PANTHOS morphology: a perinuclear rosette of Aβ-positive autolysosomes that eventually fuse into massive membrane-bound blebs, distending the neuronal plasma membrane. The progression "after" this phase is the story of the physical and biological rupture of this system.² 2. The Mechanism of Neuronal Lysis: The "Inside-Out"

Transition

The transition from the intraneuronal PANTHOS phase to the extracellular senile plaque is not a process of secretion or exocytosis, but rather a terminal event of cellular lysis. The mechanism is violent and irreversible, transforming the neuron from a functional unit into a toxic lesion. 2.1 Lysosomal Membrane Permeabilization (LMP) The structural integrity of the distended, Aβ-laden autolysosomes is the final barrier preventing neurodegeneration. The diagram implies a tipping point where this integrity is breached. This event, known as Lysosomal Membrane Permeabilization (LMP), is the "point of no return" for the neuron. The mechanisms triggering LMP in the PANTHOS neuron are multifactorial:

1. Intraluminal Aggregate Stress: The continuous accumulation of fibrillar Aβ within the lysosome exerts physical stress on the limiting membrane. Aβ aggregates have been shown to possess intrinsic membrane-destabilizing properties, potentially forming pores or acting as detergents that disrupt the lipid bilayer.³
2. ROS and Lipid Peroxidation: The failure of degradation leads to the accumulation of redox-active iron and other metals within the lysosome (the "Fenton reaction"), generating Reactive Oxygen Species (ROS). These ROS attack the lysosomal membrane lipids, causing peroxidation and increasing permeability.³
3. Beta-CTF Toxicity: The accumulation of β-CTF, the precursor to Aβ, is itself toxic. High levels of β-CTF within endosomes and autophagosomes have been linked to the disruption of vesicle trafficking and membrane integrity, further compromising the stability of the compartment.³ 2.2 The Cytosolic Invasion of Hydrolases Upon LMP, the contents of the lysosome leak into the cytoplasm. This includes not only the amyloid aggregates but, more critically, the lysosomal hydrolases. While enzymes like cathepsin D require a low pH for optimal activity, they retain significant residual activity at the neutral pH of the cytosol, or the cytosol itself may locally acidify due to the massive proton leak.⁴ The release of cathepsins (B, D, and L) acts as a dominant executioner signal. These proteases cleave cytosolic targets indiscriminately, including cytoskeletal proteins and anti-apoptotic factors (e.g., Bcl-2), initiating a rapid demolition of the cellular architecture.³ 2.3 Specific Modes of Cell Death: Beyond Apoptosis While apoptosis is the classical model of programmed cell death, the PANTHOS transition involves unique, regulated necrotic pathways that explain the specific morphology of the resulting plaque. 2.3.1 Parthanatos

Recent evidence points to parthanatos as a key driver of cell death in this context. This

pathway is distinct from apoptosis and necroptosis and is driven by the hyperactivation of Poly(ADP-ribose) polymerase 1 (PARP1).¹⁰

● Trigger: The oxidative stress and DNA damage resulting from lysosomal failure activate

PARP1.

● Mechanism: PARP1 synthesizes poly(ADP-ribose) (PAR) polymers, which act as signaling

molecules. This leads to the translocation of Apoptosis-Inducing Factor (AIF) from the mitochondria to the nucleus, causing chromatin condensation and large-scale DNA fragmentation.¹⁰

● Relevance to PANTHOS: Parthanatos typically results in membrane rupture and the

release of intracellular contents, consistent with the "Inside-Out" plaque formation model where the amyloid core is left behind as a scaffold.¹⁰ 2.3.2 Lysosomal Cell Death (LCD) This form of death is specifically triggered by LMP. The massive release of cathepsins overwhelms the cytosolic protease inhibitors (cystatins). Cathepsins cleave Bid to t-Bid, which translocates to the mitochondria to induce permeabilization, but the hallmark of LCD is the early loss of plasma membrane integrity, distinguishing it from the apoptotic blebbing that preserves organelles.⁴ 2.4 Physical Transformation: The "Ghost" Neuron The culmination of these death pathways is the dissolution of the neuronal plasma membrane. The perinuclear "rosette" of amyloid-filled vacuoles, largely insoluble and resistant to degradation, remains in the extracellular space.

● The Core: The central dense core of the senile plaque corresponds to the original

perinuclear concentration of autophagic vacuoles.

● The Halo: The diffuse amyloid surrounding the core represents the dispersion of fibrils

from the ruptured peripheral blebs.

● The Identity: Neuropathological staining often reveals that these plaques retain the

DAPI-positive nuclear signature of the host neuron for a time, effectively serving as a "tombstone" or "ghost" of the PANTHOS cell.²

Table 1: Comparative Analysis of Cell Death Mechanisms in PANTHOS

Progression

Feature Apoptosis Parthanatos Lysosomal Cell

Death (LCD)

Initiator Caspase activation PARP1 Lysosomal

(intrinsic/extrinsic) hyperactivation via Membrane DNA damage Permeabilization (LMP) Mediator Cytochrome c, Poly(ADP-ribose), Cathepsins (B, D, Caspase-3/7 AIF translocation L), t-Bid

Energy ATP-dependent ATP-depletion ATP-independent

Requirement (NAD+ (often)

consumption)

Membrane Maintained Ruptured Ruptured (early

Integrity (blebbing/apoptotic (necrosis-like) loss of integrity)

bodies)

Outcome in AD Cell shrinkage and Lysis and release of Lysis and release of

clearance plaque core plaque core

Role in PANTHOS Secondary/Late Primary driver of Primary driver of stage "Inside-Out" "Inside-Out" release release

3. The Post-Lysis Environment: Glial Invasion and

Plaque Maturation

Once the neuronal membrane ruptures, the pathology shifts from a cell-autonomous defect to a multicellular inflammatory cascade. The immune privilege of the intraneuronal aggregate is lost, and the brain's surveillance cells—microglia and astrocytes—mount a response that paradoxically exacerbates the disease. 3.1 Microglial Recruitment: The Chemotactic Surge During the intraneuronal PANTHOS phase, the pathology is largely hidden from the immune system. The cell membrane sequesters the amyloid and lysosomal debris. However, the

rupture event releases a massive bolus of Danger-Associated Molecular Patterns

(DAMPs).¹³

● Chemoattractants: Released ATP, DNA fragments, HMGB1, and the exposed amyloid

fibrils themselves act as potent chemoattractants for microglia.

● Migration: Microglia migrate toward the "ghost" neuron, transitioning from a ramified

(surveillance) state to an amoeboid (active) state.¹⁴ 3.2 The "Can Opener" Hypothesis and Frustrated Phagocytosis A critical insight from the provided research is the potential role of microglia not just as cleaners, but as facilitators of the plaque's final form. ● The "Can Opener" Effect: It is hypothesized that microglia may attack the compromised, dying PANTHOS neuron. In their attempt to phagocytose the cell, they may strip away the remaining plasma membrane, effectively "opening the can" and fully exposing the insoluble amyloid core to the extracellular space.¹⁶

● Frustrated Phagocytosis: The amyloid core, formed from compacted autophagic

vacuoles, is too large and insoluble for effective degradation. Microglia surround the plaque, forming a barrier or "halo." Unable to digest the core, they enter a state of "frustrated phagocytosis," leading to the chronic secretion of pro-inflammatory cytokines (IL-1β, TNF-α) and reactive oxygen species (ROS).³ 3.3 The Role of Lipid Metabolism and ApoE The progression is intimately tied to lipid dysregulation. The endosomal-lysosomal system is the cell's lipid sorting hub. The breakdown of this system in PANTHOS neurons leads to the accumulation of lipids (e.g., cholesterol, sphingolipids) alongside Aβ.¹⁷

● ApoE Interaction: Apolipoprotein E (ApoE), particularly the E4 isoform, plays a critical

role here. Under stress, neurons and microglia upregulate ApoE. However, in the lipid-deprived environment caused by lysosomal sequestration, microglia may take up more aggregated amyloid complexed with lipids.

● Microglial Stalling: Research indicates that lipid-rich debris from the dying neuron

exacerbates microglial dysfunction. In ApoE4 carriers, this clearance is further impaired, leading to larger plaques and more severe inflammation.¹⁷ 3.4 Astrocytic Scarring and Excitotoxicity Following microglial invasion, astrocytes are recruited to the site. They undergo astrogliosis, upregulating GFAP and extending processes to wall off the lesion. While intended to protect the surrounding neuropil, this "glial scar" has deleterious effects:

● Loss of Metabolic Support: Reactive astrocytes lose their capacity to buffer

extracellular glutamate and potassium.

● Excitotoxicity: The accumulation of glutamate around the plaque induces excitotoxic

stress in neighboring neurons, activating NMDA receptors and causing calcium overload, which accelerates neurodegeneration in the surrounding circuit.¹⁹ 4. Propagation of Pathology: The Tau Connection A central question in AD research is the relationship between amyloid plaques and neurofibrillary tangles (NFTs) composed of hyperphosphorylated tau. The "Inside-Out" model provides a mechanistic sequence that explains why tau pathology generally follows amyloid deposition in the neocortex, yet correlates better with cognitive decline. 4.1 Lysosomal Dysfunction as the Driver of Tau Aggregation The failure of the lysosome in the PANTHOS phase is directly responsible for the initial steps of tau pathology. Tau is normally degraded via the autophagy-lysosomal pathway. The stalling of this system leads to increased cytosolic concentrations of tau, increasing the probability of aggregation.³

● Cathepsin D-Mediated Truncation: The leakage of cathepsin D into the cytosol (during

the early phases of LMP) is a specific trigger. Cathepsin D can cleave tau at the C-terminus. These truncated tau fragments are highly neurotoxic and prone to rapid aggregation, serving as seeds for further filament assembly.⁶

● Inhibition of Degradation: The accumulation of β-CTF inhibits lysosomal

acidification, which reciprocally inhibits the degradation of tau, creating a feedback loop of accumulation.³ 4.2 The "Seeding" Hypothesis: Prion-Like Spread Once the PANTHOS neuron lyses, the aggregated tau species (pre-tangles or mature tangles) are released into the extracellular space alongside the amyloid core.

● Exosomal Transport: Before lysis, the stressed neuron may attempt to eject toxic tau via

exosomes. These exosomes can be taken up by neighboring neurons, seeding pathology in healthy cells.²⁰

● Direct Neuronal Uptake: Following lysis, the extracellular tau aggregates can be

endocytosed by adjacent neurons. Once inside, they act as templates, corrupting the endogenous normal tau and propagating the tangle pathology in a prion-like manner.²¹ 4.3 The Plaque-Tangle Interaction in Neighboring Cells The formation of the extracellular plaque creates a "toxic zone" that induces tau pathology in bystander neurons.

● Neuritic Dystrophy: Axons and dendrites passing through the plaque halo sustain

damage from the amyloid fibrils and the inflammatory cytokines released by microglia. These neurites swell and accumulate lysosomes, forming "dystrophic neurites".²²

● Inflammation-Induced Phosphorylation: The release of IL-1β by the

plaque-associated microglia activates kinases such as p38 MAPK and CDK5 in the surrounding neurons. These kinases hyperphosphorylate tau, leading to NFT formation in cells that were not originally PANTHOS-positive.²³

This delineates the sequence: Intraneuronal Lysosomal Failure rightarrow PANTHOS

Formation rightarrow Neuronal Lysis (Plaque Release) rightarrow Microglial

Activation rightarrow Paracrine Cytokine Signaling rightarrow Tau

Hyperphosphorylation in Neighbors.

Table 2: The Sequential Cascade of Pathological Events

Stage Biological Event Key Molecular Structural

Players Consequence

1. Initiation v-ATPase failure; APP-βCTF, Accumulation of Acidification deficit BACE1, PSEN1 autophagic vacuoles (AVs)
2. Expansion Autophagy Aβ42, LC3-II, Formation of upregulation; p62 perinuclear rosette Traffic jam (PANTHOS)
3. Transition Lysosomal Cathepsins, ROS, Membrane

Membrane PARP1 rupture; Cell

Permeabilization death (Lysis)

4. Reaction Microglial DAMPs, TREM2, Formation of "Glial chemotaxis; ApoE, ATP Halo" around Phagocytosis plaque
5. Propagation Kinase activation; IL-1β, Dystrophic Seed release GSK3β, neurites; Tau CDK5, Truncated tangles in Tau neighbors
6. Accelerated Neurodegeneration and Systemic

Ripple Effects

The diagram provided indicates a phase of "Accelerated Neurodegeneration" following the plaque formation. The "Inside-Out" model explains this acceleration as a consequence of the loss of synaptic integrity and the recruitment of systemic dysfunction. 5.1 Synaptic Collapse and Network Failure The death of the PANTHOS neuron represents an immediate loss of synaptic connectivity. However, the damage extends far beyond the single lost cell.

● Synaptic Pruning: Activated microglia, in the presence of Aβ, excessively prune

synapses in the surrounding circuit using the complement system (C1q, C3). This leads to a rapid thinning of dendritic spines in the cortical area surrounding the plaque.¹⁵

● Excitatory/Inhibitory Imbalance (ASPD): Recent research identifies the accumulation

of "Amyloid-beta Stimulated Protein D" (ASPD) in excitatory neurons. Secreted ASPD impairs the Na+/K+-ATPase (NKAα3) on inhibitory interneurons. This impairment reduces the activity of inhibitory neurons, leading to disinhibition and hyperexcitability of the remaining excitatory network. This excitotoxicity fuels further Aβ production and accelerates neuronal death, creating a feed-forward loop of degeneration.²⁵ 5.2 Axonal Lysosomal Accumulation The pathology is not limited to the soma. In AD, lysosomes accumulate massively in the axons, particularly near plaques. These axonal lysosomes are transport-incompetent and rich in BACE1, serving as local factories for Aβ production. The blockage of axonal transport leads to the "starvation" of the synapse for trophic factors (like BDNF) and the failure to clear retrograde waste, causing distal degeneration of the axon (Wallerian-like degeneration).²⁶ 5.3 Vascular and Metabolic Comorbidities The progression is exacerbated by non-neuronal factors that degrade the brain's resilience.

● Insulin Resistance: The accumulation of Aβ oligomers can bind to insulin

receptors, causing their internalization and inducing brain insulin resistance. This impairment of insulin signaling activates GSK3β, which hyperphosphorylates tau, further linking amyloid and tangle pathologies.²⁸

● Vascular Dysfunction: The deposition of amyloid in the vasculature (CAA) and the

general inflammatory state compromise the Blood-Brain Barrier (BBB). This leads to micro-hemorrhages and the infiltration of peripheral immune cells, which are less regulated than microglia and can cause severe bystander damage to neural tissue.²⁸ 6. Methodological Validation and Clinical Implications The validity of the PANTHOS model and the "Inside-Out" progression is supported by advanced methodological approaches that overcome the limitations of traditional models. 6.1 Transdifferentiation Models (tNeurons) A significant challenge in AD research has been the use of induced Pluripotent Stem Cells (iPSCs), which are reprogrammed to an embryonic state, effectively erasing the epigenetic markers of aging. Since age is the primary risk factor for AD, iPSC models often fail to recapitulate late-onset pathology. To address this, researchers have utilized transdifferentiation, converting adult fibroblasts directly into neurons (tNeurons). These cells retain the epigenetic signature of the donor's age. Studies using tNeurons from AD patients have successfully recapitulated the lysosomal defects, PANTHOS morphology, and neuronal death observed in the human brain, providing robust validation for the mechanism described in this report.30 6.2 Why Plaque Clearance Fails The most profound implication of the "Inside-Out" mechanism is its explanation for the failure of anti-amyloid therapies to reverse cognitive decline. If the senile plaque is the "tombstone" of a neuron that has already died via the PANTHOS pathway, then removing the plaque is akin to clearing rubble after a building has collapsed; it does not restore the building. Therapies that target extracellular amyloid are addressing the result of the pathology, not the cause. The widespread death of neurons occurred before the plaque became accessible to the antibody. This suggests that effective intervention must target the intraneuronal phase—specifically, strategies to restore v-ATPase function, re-acidify lysosomes, and enhance autophagic flux before membrane permeabilization occurs.5 6.3 Biomarker Implications The "Inside-Out" model implies that markers of lysosomal dysfunction (e.g., elevated cathepsins in CSF or plasma, or specific lysosomal membrane proteins) should precede markers of amyloid deposition (PET positivity). This aligns with the diagram's timeline where "Intraneuronal" pathology peaks before "Beta-amyloid plaques" become detectable. This temporal separation offers a new window for early diagnosis and preventative treatment.¹¹ 7. Conclusion The mechanism for the progression of Alzheimer's disease after the intraneuronal phase is

structurally and molecularly defined by the conversion of intracellular lysosomal pathology into extracellular lesions through a specific process of neuronal death. The

diagram referenced by the user illustrates a transition that is not a passive secretion of amyloid, but a catastrophic failure of the endosomal-lysosomal system leading to cell lysis. This "Inside-Out" mechanism redefines the senile plaque as a remnant of a fallen neuron—a "ghost"—rather than a precipitate from the extracellular fluid. The subsequent progression involves a reactive cascade where glial cells, recruited by the chemical signature of cell rupture, attempt to clear the debris but are thwarted by its insolubility. This leads to chronic neuroinflammation, the "can opener" effect exposing the plaque core, and the paracrine activation of tau pathology in neighboring cells. Driven by synaptic disconnection, excitotoxicity, and metabolic failure, this cascade results in the accelerated neurodegeneration that characterizes the clinical dementia of Alzheimer's disease. This comprehensive understanding shifts the therapeutic imperative from clearing extracellular plaques to preserving the integrity of the neuronal lysosome and preventing the initial membrane permeabilization event.

Works cited

1. Ralph A. Nixon, MD, PhD - NYU Grossman School of Medicine, accessed November 20, 2025, https://med.nyu.edu/faculty/ralph-a-nixon

2. Lee JH, Yang DS, Goulbourne CN, Im E, Stavrides P, Pensalfini A, et al.. Faulty autolysosome acidification in Alzheimer's disease mouse models induces autophagic build-up of Aβ in neurons, yielding senile plaques. Nat Neurosci 2022;25(6):688-701. DOI 10.1038/s41593-022-01084-8.

3. Nixon RA. Autophagy-lysosomal-associated neuronal death in neurodegenerative disease. Acta Neuropathol 2024;148(1):42. DOI 10.1007/s00401-024-02799-7.

4. Lee JH, Yang DS, Goulbourne CN, Im E, Stavrides P, Pensalfini A, et al.. Faulty autolysosome acidification in Alzheimer's disease mouse models induces autophagic build-up of Aβ in neurons, yielding senile plaques. Nat Neurosci 2022;25(6):688-701. DOI 10.1038/s41593-022-01084-8.

5. Nixon RA, Rubinsztein DC. Mechanisms of autophagy-lysosome dysfunction in neurodegenerative diseases. Nat Rev Mol Cell Biol 2024;25(11):926-946. DOI 10.1038/s41580-024-00757-5.

6. Khurana V, Elson-Schwab I, Fulga TA, Sharp KA, Loewen CA, Mulkearns E, et al.. Lysosomal Dysfunction Promotes Cleavage and Neurotoxicity of Tau In Vivo. PLoS Genetics 2010;6(7):e1001026. DOI 10.1371/journal.pgen.1001026.

7. Korte M, Köster RW. Opening the box of PANTHORA in Alzheimer's disease. Signal Transduct Target Ther 2022;7(1):344. DOI 10.1038/s41392-022-01204-7.

8. Mitochondrial accumulation and lysosomal dysfunction result in mitochondrial plaques in Alzheimer's disease - bioRxiv, accessed November 20, 2025, DOI 10.1101/2025.02.19.639081">https://www.biorxiv.org/content/10.1101/2025.02.19.639081

9. Jiang Y, Sato Y, Im E, Berg M, Bordi M, Darji S, et al.. Lysosomal Dysfunction in Down Syndrome Is APP-Dependent and Mediated by APP-βCTF (C99). The Journal of Neuroscience 2019;39(27):5255-5268. DOI 10.1523/jneurosci.0578-19.2019.

10. Moura RD, Mattos PD, Valente PF, Hoch NC. Molecular mechanisms of cell death by parthanatos: More questions than answers. Genet Mol Biol 2024;47Suppl 1(Suppl 1):e20230357. DOI 10.1590/1678-4685-GMB-2023-0357.

11. Nixon RA. Autophagy-lysosomal-associated neuronal death in neurodegenerative disease. Acta Neuropathol 2024;148(1):42. DOI 10.1007/s00401-024-02799-7.

12. Leon S, Simon V, Lee TH, Steuernagel L, Clark S, Biglari N, et al.. Single cell tracing of Pomc neurons reveals recruitment of 'Ghost' subtypes with atypical identity in a mouse model of obesity. Nat Commun 2024;15(1):3443. DOI 10.1038/s41467-024-47877-2.

Ghost'_subtypes_with_atypical_identity_in_a_mouse_model_of_obesity/links/662 9c6df06ea3d0b74012fd7/Single-cell-tracing-of-Pomc-neurons-reveals-recruitm ent-of-Ghost-subtypes-with-atypical-identity-in-a-mouse-model-of-obesity.pdf

13. Haidar MA, Ibeh S, Shakkour Z, Reslan MA, Nwaiwu J, Moqidem YA, et al.. Crosstalk between Microglia and Neurons in Neurotrauma: An Overview of the Underlying Mechanisms. Curr Neuropharmacol 2022;20(11):2050-2065. DOI 10.2174/1570159X19666211202123322.

14. Umpierre AD, Wu LJ. How microglia sense and regulate neuronal activity. Glia 2021;69(7):1637-1653. DOI 10.1002/glia.23961.

15. Hu Y, Tao W. Current perspectives on microglia-neuron communication in the central nervous system: Direct and indirect modes of interaction. J Adv Res 2024;66:251-265. DOI 10.1016/j.jare.2024.01.006.

16. Korte M, Köster RW. Opening the box of PANTHORA in Alzheimer's disease. Signal Transduct Target Ther 2022;7(1):344. DOI 10.1038/s41392-022-01204-7.

17. A Match Made in Microglia? ApoE and Aβ Click in Lysosomes, Seeding Plaque - Alzforum, accessed November 20, 2025, https://www.alzforum.org/news/research-news/match-made-microglia-apoe-an d-av-click-lysosomes-seeding-plaque

18. Zhang XW, Zhu XX, Tang DS, Lu JH. Targeting autophagy in Alzheimer's disease: Animal models and mechanisms. Zool Res 2023;44(6):1132-1145. DOI 10.24272/j.issn.2095-8137.2023.294.

19. Neurodegenerative Diseases - California Life Sciences, accessed November 20, 2025, https://www.califesciences.org/wp-content/uploads/2023/04/LSI-Neurodegenera tive-Diseases.pdf

20. PANTHOS neurons evolve into classical dense-cored senile plaques in AD... - ResearchGate, accessed November 20, 2025, https://www.researchgate.net/figure/PANTHOS-neurons-evolve-into-classical-de nse-cored-senile-plaques-in-AD-models-a_fig8_361040251

21. Bloom GS. Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis. JAMA Neurol 2014;71(4):505-8. DOI 10.1001/jamaneurol.2013.5847.

22. Tsering W, Prokop S. Neuritic Plaques - Gateways to Understanding Alzheimer's Disease. Mol Neurobiol 2024;61(5):2808-2821. DOI 10.1007/s12035-023-03736-7.

23. Medeiros R, Baglietto-Vargas D, LaFerla FM. The role of tau in Alzheimer's disease and related disorders. CNS Neurosci Ther 2011;17(5):514-24. DOI 10.1111/j.1755-5949.2010.00177.x.

24. Inflammation may spur abnormal tau tangles, new mouse study shows, accessed November 20, 2025, https://www.nia.nih.gov/news/inflammation-may-spur-abnormal-tau-tangles-ne w-mouse-study-shows

25. How Alzheimer's Aβ propagates and triggers tau pathology in intact neurons - bioRxiv, accessed November 20, 2025, https://www.biorxiv.org/content/

26. Axonal Organelle Buildup from Loss of AP-4 Complex Function Causes Exacerbation of Amyloid Plaque Pathology and Gliosis in Alzheimer's Disease Mouse Model | eNeuro, accessed November 20, 2025, https://www.eneuro.org/content/11/12/ENEURO.0445-24.2024

27. Ralph A. Nixon, MD, PhD laboratory | Center for Dementia Research, accessed November 20, 2025, https://www.cdr.rfmh.org/research/nixon-lab/

28. Calabrò M, Rinaldi C, Santoro G, Crisafulli C. The biological pathways of Alzheimer disease: a review. AIMS Neurosci 2021;8(1):86-132. DOI 10.3934/Neuroscience.2021005.

29. Chan JC. Alzheimer's disease model explains Alzheimer's disease incidences. J Alzheimers Dis Rep 2025;9:25424823251395616. DOI 10.1177/25424823251395616.

30. Better Cell Model? Transdifferentiated Neurons Capture AD-Like Changes | ALZFORUM, accessed November 20, 2025, https://www.alzforum.org/news/research-news/better-cell-model-transdifferenti ated-neurons-capture-ad-changes

31. Nixon Lab Provides Further Evidence for Alternative Alzheimer's Theory, accessed November 20, 2025, https://www.nki.rfmh.org/nixon-lab-provides-further-evidence-for-alternative-al zheimers-theory/

32. Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, et al.. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011;7(3):280-92. DOI 10.1016/j.jalz.2011.03.003.

The Validity Ledger

The argument above is only as strong as its weakest load-bearing joint, and the reader is owed an explicit accounting of where it stands on the ground and where it stands on inference.